Replimune Group Inc. (REPL)

Trade REPL now with
12/7/2022 7:14:10 AM Replimune Announces Positive Initial Data From Anti-PD1 Failed Melanoma Cohort Of IGNYTE Clinical Trial
10/7/2022 8:08:52 AM Replimune Obtains $200 Mln Non-dilutive Term Loan Facility From Hercules Capital
5/19/2022 8:40:00 AM Replimune Q4 Net Loss $31.7 Mln Vs Loss Of $21.5 Mln Last Year
1/5/2021 8:25:30 AM Replimune Doses First Patient In Phase 1 Clinical Trial Of RP3
4/24/2019 9:36:27 PM Wedbush Starts Replimune Group Inc. (REPL) At Outperform With $24 Price Target